Keywords: Merck & Co, Financial results fourth-quarter and full-year 2010, Galapagos

Merck & Co posts fourth-quarter 2010 loss of $531 million as a result of charges; drops alliance with Galapagos

Article | 04 February 2011

Print This

US drugs giant Merck & Co (NYSE: MRK) saw its shares fall 3.7% to $32.57 2.7% shortly after the markets opened yesterday, as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in